- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03651908
Comparison Between Bioactive Silica Graft Plus Platelet Rich Fibrin and Only Platelet Rich Fibrin Graft in Intrabony Defects With Diabetes (CBBSGPPOPIDWD)
Evaluation of Efficacy of Bioactive Silica Graft With Platelet Rich Fibrin Vs Bioactive Silica Graft Alone In The Treatment Of Intrabony Defects In Patients With Type II Diabetes Mellitus -A Randomized Clinical Study.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Platelet rich fibrin has emerged as one of the promising regenerative material.It is a second generation platelet concentrate and is defined as an autologous leucocyte-and platelet-rich fibrin biomaterial.Platelet-rich fibrin membrane consists of a fibrin 3-D polymerized matrix in a specific structure ,with the incorporation of almost all the platelets and more than half of leucocytes along with growth factors.It enhance the stabilization and revascularization of the flaps and grafts.
Bioactive silica graft (Novabone dental putty )is being used for regenerative procedures is a premixed composite of bioactive calcium -phospho-silicate particulate which is composed solely of elements that exist naturally in normal bone (ca,p,na,si,o) and an absorbable binder which is a combination of polyethylene glycol and glycerine.Treatment of intrabony defects with bioactive silica graft has led to clinically and statistically significant probing depth reduction ,relative attachment level gain and radiographic osseous defect fill.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Telangana
-
Hyderabad, Telangana, India, 500060
- Panineya institute of dental sciences and research center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Two or three walled defects With relative clinical attachment loss ≥3mm Probing depth≥5mm Patients with known diabetes(Type 2 hbA1c 6 to 7.4)
Exclusion Criteria:
- One wall defects Other systemically compromised patients Non- compliant patients Individuals allergic to medication Pregnant or lactating mothers Smokers
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Interventional
Interventional The Group A subjects will be treated with conventional flap surgery.After reflection of the full thickness flap,the intrabony defects will be debrided and Bioactive silicate graft mixed with PRF will be used as graft material to fill the defects.
|
After administering local anaesthetic a full thickness flap will be raised and reflected to expose the intrabony defects.The intrabony defects would then the debrided and grafts secured in position.Later the flap would be sutured back. After administering local anaesthetic a full thickness flap will be raised and reflected to expose the intrabony defects.The intrabony defects would then the debrided and grafts secured in position.Later the flap would be sutured back. |
|
Aktiv komparator: Interventional comparator
Group B patients will also be treated by conventional flap surgery,employing a full thickness flap technique.The intrabony defects will be filled with Bioactive silicate only.
|
After administering local anaesthetic a full thickness flap will be raised and reflected to expose the intrabony defects.The intrabony defects would then the debrided and grafts secured in position.Later the flap would be sutured back. After administering local anaesthetic a full thickness flap will be raised and reflected to expose the intrabony defects.The intrabony defects would then the debrided and grafts secured in position.Later the flap would be sutured back. |
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Radiographic parameters - Change in bone level
Tidsramme: Baseline and 9 months post surgery.
|
Amount of bone fill in the intrabony defect (Change in bone level) to be measured by Cone Beam Computed Tomography (CBCT)
|
Baseline and 9 months post surgery.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
clinical parameters - Changes in relative clinical attachment level
Tidsramme: Baseline and 9 months post surgery
|
Changes in relative clinical attachment level will be measured by UNC -15 probe in millimeters in the intrabony defect area
|
Baseline and 9 months post surgery
|
Samarbeidspartnere og etterforskere
Etterforskere
- Studieleder: Veerendra nath Reddy, MDS, panineeya institute of dental sciences and research center
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Grover V, Kapoor A, Malhotra R, Uppal RS. Evaluation of the efficacy of a bioactive synthetic graft material in the treatment of intrabony periodontal defects. J Indian Soc Periodontol. 2013 Jan;17(1):104-10. doi: 10.4103/0972-124X.107484.
- Sharma A, Pradeep AR. Treatment of 3-wall intrabony defects in patients with chronic periodontitis with autologous platelet-rich fibrin: a randomized controlled clinical trial. J Periodontol. 2011 Dec;82(12):1705-12. doi: 10.1902/jop.2011.110075. Epub 2011 Apr 5.
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- sravanthinovabone
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Intrabony periodontal defekt
-
Semmelweis UniversityRekrutteringIntrabony periodontal defektUngarn
-
Dr R Viswa ChandraRekrutteringIntrabony periodontal defektIndia
-
Nova Southeastern UniversityRekruttering
-
Necmettin Erbakan UniversityAktiv, ikke rekrutterendePeriodontal intrabony defektTyrkia
-
Mansoura UniversityFullførtIntrabony periodontal defektEgypt
-
October 6 UniversityFullført
-
Semmelweis UniversityGeistlich Pharma AG; Schupbach Ltd.FullførtIntrabony periodontal defektUngarn
-
Ain Shams UniversityFullførtIntrabony periodontal defekt
-
Krishnadevaraya College of Dental Sciences & HospitalHar ikke rekruttert ennå
-
Istituto Ortopedico GaleazziRekruttering
Kliniske studier på Conventional Flap Surgery
-
St. Paul's Sinus CentreHar ikke rekruttert ennåKronisk bihulebetennelse | Skull Base Neoplasms | Tumor i nasal sinus | Bakre neseblødning
-
Javaid AfridiFullførtHypospadier | Distale penishypospadier (lidelse)Pakistan
-
University Hospital Inselspital, BerneFullført
-
Recep Tayyip Erdogan UniversityPåmelding etter invitasjon
-
Bulent Ecevit UniversityFullførtPeriodontale sykdommer | Periodontitt, aggressiv | Diode laserterapi
-
The Cleveland ClinicTilbaketrukket
-
Armed Forces Institute of Dentistry, PakistanFullførtPeriodontitt | Periodontale intrabony defekterPakistan
-
Fondazione IRCCS Policlinico San Matteo di PaviaRekrutteringRekonstruktiv kirurgi | Hode- og hals mikrovaskulær fri flappItalia
-
Johns Hopkins UniversityAxogen CorporationAvsluttetBrystkreft | Brystrekonstruksjon | Sensorisk restaureringForente stater
-
Anhui Provincial Cancer HospitalAnhui Provincial HospitalRekruttering